49T-11394-57929

3 vaccinations 8 coded responses 40 check-ins 8 free-text entries 6 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 559 / MN
Registered: 2021-02-17

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2162896 (opens in a new window)	high	11 / 11	—	3 of 6 VAERS symptoms	same dose (3)	MN matches	2022-02-18 / 2022-02-25 / 2022-03-07 received the same day as the last call	case 291772

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-17
Registered in v-safe
2021-02-17
Dose 1 — Pfizer-BioNTech
2021-02-17
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work

Adult check-in
2021-02-17
Report sent to call center — day 0, dose 1
Be unable to work

1 call case(s)
2021-02-18
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-02-18
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-02-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-02-20
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-02-20
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-02-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-02-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-02-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-02-24
Health check-in — day 7, dose 1
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-02-24
Report sent to call center — day 7, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-03-04
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-11
Dose 2 — Pfizer-BioNTech
2021-03-11
Survey response — day 0, dose 2
MedDRA: Blood pressure increased, Dizziness — Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Free text: Increased blood pressure and lightheadedness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-12
Survey response — days 1–6 daily, dose 2
MedDRA: Asthenia, Blood pressure increased — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Free text: Weakness and increase in blood pressure

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-14
Survey response — days 1–6 daily, dose 2
MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Lack of appetite

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-18
Health check-in — day 7, dose 2
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-03-25
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-01
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-08
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-15
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-17
Pregnancy registry survey
Pregnant at time of vaccination · Yes, I would like someone to contact me
2021-04-22
Survey response — day 42, dose 2
MedDRA: Pregnancy, Unevaluable event — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Symptoms: Fetal 3rd degree AV block with arrhythmia and decreased fetal movement. My heart is inflamed with an autoimmune flare and arrhythmia. We are now an extremely high risk pregnancy with risk of demise. · Healthcare visit (other): OB Triage

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-22
Report sent to call center — day 42, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-28
Call 1 — Could Not Reach Participant
2021-05-03
Call 2 — Could Not Reach Participant
2021-06-10
Health check-in — 3 months, dose 2
Feeling: Poor

Adult check-in
2021-09-09
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2022-02-18
Dose 3 — Pfizer-BioNTech
2022-02-18
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain, Redness · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-02-19
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-02-20
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2022-02-21
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-02-22
Survey response — days 1–6 daily, dose 3
MedDRA: Pruritus — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Itching

MedDRA releases: 2024-11 · check-in free text available
2022-02-23
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-02-24
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-02-25
Health check-in — day 7, dose 3
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-03-04
Survey response — day 14, dose 3
MedDRA: Chest pain, Fatigue, Inflammation, Medical counselling, Poor peripheral circulation, Skin discolouration — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: Poor circulation in the left foot (purple toes) and left to central chest pains. Fatigue has increased as well as my inflammation. · Healthcare visit (other): Emailed physician on symptoms, but did not have any tests done due to financial burden.

MedDRA releases: 2024-11 · check-in free text available
2022-03-04
Report sent to call center — day 14, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2022-03-07
Call 1 — Left Voicemail
2022-03-07
Call successful
Completed over the phone
2022-03-11
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2022-03-18
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2022-03-25
Survey response — day 35, dose 3
MedDRA: Chest pain, Fatigue, Headache, Medical counselling, Muscular weakness — Feeling: Good · Be unable to do your normal daily activities

Free text: Increased headaches that I haven't had until all my covid vaccinations. I also get on and off chest pain that my physician is aware of. An adverse event was reported. Fatigue and muscle weakness are other lingering symptoms.

MedDRA releases: 2024-11 · check-in free text available
2022-04-01
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-05-20
Health check-in — 3 months, dose 3
Feeling: Fair

Adult check-in
2022-08-19
Survey response — 6 months, dose 3
MedDRA: Brain fog, Dyspnoea, Fatigue, Headache, Neuropathy peripheral — Feeling: Good · Be unable to do your normal daily activities

Free text: Neuropathies, brain fog, headaches, shortness of breath, fatigue

MedDRA releases: 2024-11 · check-in free text available
2023-02-18
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-17	Pfizer-BioNTech
2	2021-03-11	Pfizer-BioNTech
3	2022-02-18	Pfizer-BioNTech	No

Call center

6 call center cases

2 successful · 4 priority 2/3 (triaged and no follow up)

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 5 — day 0, dose 2

2021-03-11

Systemic reaction (other): Increased blood pressure and lightheadedness

Release 5 — days 1–6 daily, dose 2

2021-03-12

Systemic reaction (other): Weakness and increase in blood pressure

2021-03-14

Systemic reaction (other): Lack of appetite

Release 7 — day 42, dose 2

2021-04-22

Symptoms: Fetal 3rd degree AV block with arrhythmia and decreased fetal movement. My heart is inflamed with an autoimmune flare and arrhythmia. We are now an extremely high risk pregnancy with risk of demise.

Healthcare visit (other): OB Triage

Release 11 — days 1–6 daily, dose 3

2022-02-22

Systemic reaction (other): Itching

Release 11 — day 14, dose 3

2022-03-04

Symptoms: Poor circulation in the left foot (purple toes) and left to central chest pains. Fatigue has increased as well as my inflammation.

Healthcare visit (other): Emailed physician on symptoms, but did not have any tests done due to financial burden.

Release 11 — day 35, dose 3

2022-03-25

Symptoms: Increased headaches that I haven't had until all my covid vaccinations. I also get on and off chest pain that my physician is aware of. An adverse event was reported. Fatigue and muscle weakness are other lingering symptoms.

Release 12 — 6 months, dose 3

2022-08-19

Symptoms: Neuropathies, brain fog, headaches, shortness of breath, fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Medical counselling	·	·	✓
HCVO	Unevaluable event	✓	✓	✓
SD	Brain fog	·	·	✓
SD	Chest pain	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Inflammation	·	·	✓
SD	Medical counselling	·	·	✓
SD	Muscular weakness	·	·	✓
SD	Neuropathy peripheral	·	·	✓
SD	Poor peripheral circulation	·	·	✓
SD	Pregnancy	✓	✓	✓
SD	Skin discolouration	·	·	✓
SRO	Asthenia	✓	✓	✓
SRO	Blood pressure increased	✓	✓	✓
SRO	Decreased appetite	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Pruritus	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release